Fundraising Fox
エディットフォース
Fukuoka, JP · Founded 2015 · 4 known investors
Find your way into エディットフォース
Sign up to see every warm intro you have to エディットフォース
- Paths you didn't know you had: your email and LinkedIn already hold routes to the エディットフォース team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries. The company aims to advance therapeutic drug development and address challenges in health, food, and environmental sectors.
Founders & leadership
Investors · 4
How we know: Global Brain's portfolio page · Not right? Tell us
How we know: KDDI Open Innovation Fund's portfolio page · Not right? Tell us
How we know: Newton Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: UTEC's portfolio page · Not right? Tell us
Frequently asked questions
- What does エディットフォース do?
- EditForce develops proprietary PPR gene-editing technology that can modify both DNA and RNA, with applications in medicine, agriculture, and chemical industries. The company aims to advance therapeutic drug development and address challenges in health, food, and environmental sectors.
- Who are エディットフォース's investors?
- エディットフォース's investors include Global Brain, KDDI Open Innovation Fund, Newton Biocapital, UTEC.
- Where is エディットフォース headquartered?
- エディットフォース is headquartered in Fukuoka, JP.